Skip to main content
Clinical Trials/NCT05546177
NCT05546177
Not Yet Recruiting
N/A

Effect Of Instrumented Assisted Soft Tissue Mobilization On Pain, Function And Proprioception In Patients With Shoulder Impingement Syndrome. A Randomised Controlled Trial

Cairo University0 sites80 target enrollmentSeptember 25, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Shoulder Impingement
Sponsor
Cairo University
Enrollment
80
Primary Endpoint
pain intensity
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

this study will be conducted to investigate instrumented Assisted Soft Tissue Mobilization On Pain, Function And Proprioception In Patients With Shoulder Impingement Syndrome

Detailed Description

Shoulder impingement is a clinical syndrome in which soft tissues become painfully entrapped in the area of the shoulder joint. Patients present with pain on elevating the arm or when lying on the affected side. Shoulder pain is the third most common musculoskeletal complaint in orthopedic practice, and impingement syndrome is one of the more common underlying diagnoses. On the pathophysiological level, it can have various functional, degenerative, and mechanical causes. The impingement hypothesis assumes a pathophysiological mechanism in which different structures of the shoulder joint come into mechanical conflict. The decision to treat conservatively or surgically is generally made on the basis of the duration and severity of pain, the degree of functional disturbance, and the extent of structural damage. The goal of treatment is to restore pain-free and powerful movement of the shoulder joint.Instrument-assisted soft tissue mobilization (IASTM) is a popular treatment for myofascial restriction which is applied using specially designed instruments to provide a mobilizing effect to soft tissue (e.g., scar tissue and myofascial adhesion) to decrease pain and improve range of motion (ROM) and function. eighty patients will be allocated randomly into two equal groups; the experimental one will receive IASTM and the control will receive traditional therapy for eight weeks.

Registry
clinicaltrials.gov
Start Date
September 25, 2022
End Date
April 30, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nabil Mahmoud Ismail Abdel-Aal

Nabil mahmoud ismail

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients with impingement syndrome from both genders.
  • Age range from 25-40 years
  • Body mass index 18.5-24.9 kg/m2
  • Subjects are non-smokers.
  • Shoulder impingement symptoms lasting at least 6 weeks

Exclusion Criteria

  • Hand truma, present pain or other kinds of complaints in the hand area.
  • History of deformities, fractures, or surgery of the tested upper extremity joints affecting hand grip strength within the last 6 months.
  • Presence of cardiopulmonary, hormonal disorder, central or peripheral neurological deficits or any condition that can influence the results.

Outcomes

Primary Outcomes

pain intensity

Time Frame: up to eight weeks

pain will be measured by visual analogue scale. It is a vertical or horizontal 100 mm line graduated by different levels of pain, starting from 0 (no pain) till 100 (worst pain)

shoulder disability

Time Frame: up to eight weeks

The Arabic version of Disabilities of arm, shoulder, and hand (DASH) will be used for assessing shoulder function. DASH questionnaire includes 30 items with score from 0 to 100. A score of 0 represents no disability, while a score of 100 represents the most sever.

Secondary Outcomes

  • rounded shoulder(up to eight weeks)
  • shoulder proprioception(up to eight weeks)
  • shoulder range of motion(up to eight weeks)

Similar Trials